HealthDay on MSN7d
Several Factors Play Role in Semaglutide Initiation for Obesity Without Diabetes
The researchers found that 2.0 percent of individuals initiated semaglutide within six months of their initial ... “These ...
EurekAlert!10d
Factors associated with semaglutide initiation among adults with obesity
This cohort study found that key sociodemographic, health care, and clinical factors are associated with receipt of semaglutide, a novel glucagon-like peptide-1 (GLP-1) receptor agonist medication, in ...
Armed robbery in Revesby10d
Semaglutide Use Factors in Adults With Obesity
This cohort study found that key sociodemographic, health care, and clinical factors are associated with receipt of semaglutide, a ...
Healio2d
FDA approves new indication for Ozempic to lower kidney risks in type 2 diabetes, CKD
The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and cardiovascular death among adults with type 2 diabetes and chronic kidney ...
The American Journal of Managed Care3d
FDA Expands Semaglutide Use for CV, Kidney Risks in T2D, CKD
Semaglutide is now approved for T2D patients with CKD, reducing cardiovascular and kidney disease risks. The FLOW phase 3b trial showed significant reductions in adverse kidney and cardiovascular ...